Clinical trials sponsored by European Organisation for Research and Treatment of Cancer - EORTC

Phase breakdown

Conditions studied

Recruiting trials led by European Organisation for Research and Treatment of Cancer - EORTC

• Adjuvant Tebentafusp in High Risk Ocular Melanoma
  NCT06246149 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
  NCT05974774 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: Male · 9 locations
• PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
  NCT04790253 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 41 locations
• Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
  NCT04498767 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 13 locations

Common questions

How many trials is European Organisation for Research and Treatment of Cancer - EORTC recruiting for?

European Organisation for Research and Treatment of Cancer - EORTC is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.